Harvard Bioscience to acquire Data Sciences International and sells Denville Scientific
Harvard Bioscience has entered into a definitive merger agreement to acquire 100% of the outstanding stock of Data Sciences International for approximately $70 million. Simultaneously, the Company completed the sale of its subsidiary Denville Scientific to Thomas Scientific for $20 million. January 22, 2018